For the Inventor, By the Inventor

Enter assignee name

Jsc Grindeks

USPTO Granted Patents = 9

Forward Citations = 7

Loading Chart...

Loading Chart...

35 inventors (with patents filed for the assignee):

Ivars Kalvins (5 out of 15 patents)

Maija Dambrova (5 out of 8 patents)

Einars Loza (4 out of 18 patents)

4. Edgars Liepins (4 out of 4 patents)

5. Janis Kuka (4 out of 4 patents)

6. Osvalds Pugovics (4 out of 4 patents)

7. Solveiga Grinberga (4 out of 4 patents)

8. Ilmars Stonans (3 out of 4 patents)

9. Reinis Vilskersts (3 out of 3 patents)

10. Inese Reine (2 out of 5 patents)

11. Daina Lola (2 out of 2 patents)

12. Ivars Kalvinsh (2 out of 7 patents)

13. Armands Zandersons (2 out of 2 patents)

14. Liga Zvejniece (1 out of 4 patents)

15. Grigorijs Veinbergs (1 out of 2 patents)

9 patents: Sort by Forward Citations

1. 10351534 - Use of 3-carboxy-N-ethyl-N,N-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease (2019-07-16),

2. 9573882 - Use of 4-[ethyl(dimethyl)ammonio]butanoate in the treatment of cardiovascular disease (2017-02-21),

3. 9278907 - Use of 4-[ethyl(dimethyl)ammonio]butanoate in the treatment of cardiovascular disease (2016-03-08),

4. 8940793 - 4-[(haloalkyl)(dimethyl)ammonio]butanoates and use thereof in the treatment of cardiovascular disease (2015-01-27),

5. 8791273 - [object Object] (2014-07-29),

6. 8492413 - Pharmaceutical combination of 5-fluorouracil and derivate of 1,4-dihydropyridine and its use in the treatment of cancer (2013-07-23),

7. 8431717 - [object Object] (2013-04-30),

8. 8119835 - Method for preparation of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphtoic acid (2012-02-21),

9. 7902377 - Method for preparing medetomidine and its salts (2011-03-08),

JSC Grindeks is a pharmaceutical company based in Latvia, specializing in the development, manufacturing, and sales of pharmaceutical products. With a history dating back to 1991, the company has established itself as a leading provider of high-quality medications and active pharmaceutical ingredients. Grindeks' portfolio includes products for various therapeutic areas, including cardiology, neurology, and psychiatry. The company is committed to innovation and continuous improvement in order to increase the effectiveness and safety of its products.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

9 Patents

#1 in Riga

#2 in Latvia

Jsc Grindeks

Forward Citations = 7

35 inventors:

Ivars Kalvins (5 out of 15 patents)

Maija Dambrova (5 out of 8 patents)

Einars Loza (4 out of 18 patents)

4. Edgars Liepins (4 out of 4 patents)

5. Janis Kuka (4 out of 4 patents)

Please report any incorrect information to support@idiyas.com

Loading…